[1] Rubbia-Brandt L, Audard V, Sartoretti P, et al.Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol, 2004, 15: 460-466.
[2] Yamashita S, Shindoh J, Mizuno T, et al.Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases. J Hepatol, 2017, 67:56-64.
[3] Zorzi D, Laurent A, Pawlik TM, et al.Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg, 2007, 94:274-286.
[4] Zhao J, Van Mierlo KMC, Gomez-Ramirez J, et al.The influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases: a systematic review and individual participant data analysis. Br J Surg, 2017.
[In press].
[5] Ribero D, Wang H, Donadon M, et al.Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer, 2007, 110:2761-2767. |
